GLP-1 Therapies: Safety and Clinical Considerations GLP-1based therapies, including newer dual- and triple-agonists targeting GLP-1, GIP, and glucagon pathways, offer substantial metabolic benefits but require thoughtful use [29]
Compared to insulin users, semaglutide was linked to a 32% lower risk for medical encounters related to tobacco use disorder, according to an observational study of 222,942 new users of diabetes medications
Pervej Alom Barbhuiya, Manash Pratim Pathak Current Obesity Reports .2026;[Epub] CrossRef DNA hypermethylation of choline kinases drives blockage of choline-phosphatidylcholine biosynthesis: lipidomic biomarkers and epigenetic insights of hepatic steatosis induced by arsenic Qiwen Fu, Qi Wang, Dingyi Song, Xingcheng Zhou, Hualin Chen, Shaofeng Wei, Lu Ma BMC Medicine .2026;[Epub] CrossRef Comments on Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection Preeti Lamba Journal of the Formosan Medical Association .2026;[Epub] CrossRef Association between triglyceride glucose-body mass index and metabolic dysfunction-associated steatotic liver disease in South Korean pregnant women Yuqin Shen, Dongqian Yang, Li Zhang, Rong Shuai Scientific Reports .2026;[Epub] CrossRef Combined effect of MASLD and low muscle strength on the risk of osteoporotic fractures: A UK Biobank cohort study Yongin Cho, Jong Hyun Jhee, Jong Ho Jhee, Hye-Sun Park European Journal of Endocrinology .2026
CrossRef Hypertension in middle childhood Mirjam Monik, Zala Hrovat, Sonja Golob Jani, Martina Filipi, Mladen Crnobrnja, Nataa Marun Varda BMC Pediatrics .2026;[Epub] CrossRef Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis Akash Roy, Surabhi Jajodia, Shardhya Chakraborty, Shruti Keyal, Awanish Tewari, Nikhil Sonthalia, Sourish Roy, Rajat Khandelwal, Anand Kulkarni, Uday Chand Ghoshal, Rajender Reddy, Mahesh Kumar Goenka BMC Gastroenterology .2026;[Epub] CrossRef Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities Veronika A
